## Abstract Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that activates multiple signaling pathways, including phosphatidylinositolβ3βkinase/vβAKT murine thymoma viral oncogene homolog protein (Akt), has long been a target of novel therapies. Despite universal EGFR expression
β¦ LIBER β¦
Targeting EGFR resistance networks in head and neck cancer
β Scribed by Vladimir Ratushny; Igor Astsaturov; Barbara A. Burtness; Erica A. Golemis; Joshua S. Silverman
- Book ID
- 113528309
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 653 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0898-6568
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Mechanisms of resistance to EGFR inhibit
β
Jonathan B. Cooper; Ezra Eddy Wyssam Cohen
π
Article
π
2009
π
John Wiley and Sons
π
English
β 209 KB
Preclinical modeling of EGFR inhibitor r
β
Quesnelle, Kelly M.; Wheeler, Sarah E.; Ratay, Mary K.; Grandis, Jennifer R.
π
Article
π
2012
π
Landes Bioscience
π
English
β 904 KB
Targeting Angiogenesis in Head and Neck
β
Tanguy Y. Seiwert; Ezra E.W. Cohen
π
Article
π
2008
π
Elsevier Science
π
English
β 477 KB
Relationship Between Environmental Carci
β
Ta-Chung Chao
π
Article
π
2010
π
Elsevier Science
π
Chinese
β 139 KB
TGF-Ξ± and EGFR in head and neck cancer
β
Jennifer R. Grandis; David J. Tweardy
π
Article
π
1993
π
John Wiley and Sons
π
English
β 340 KB
The upper aerodigestive tract mucosa of patients who develop squamous cell carcinoma of the head and neck (SCCHN) is predisposed to abnormally regulated growth, evidenced by the high incidence of synchronous and metachronous malignancies. We conducted a series of experiments to show that aberrant re
Resistance to EGFR kinase inhibitor PD15
β
Mark James Jameson; Andrew D. Beckler; Christopher Y. Thomas; Michael J. Weber;
π
Article
π
2004
π
SAGE Publications
π
English
β 35 KB